|
|
The Hectorol Start Card provides all patients with a free 30-day supply of Hectorol capsules.* Individuals with private insurance or without insurance coverage can also use it to receive their next 5 refills for $5 each. †
Using the card is easy
Just give the pharmacist a valid, signed prescription for Hectorol, along with the Hectorol Start Card.
- Patient’s insurance determines which side of the card may be used. Medicare/Medicaid and other government-insured patients may use only the voucher side of the card to obtain the free 30-day supply. All other patients may use only the debit side of the card to obtain the free 30-day supply and 5 refills for $5 each. †
- Genzyme is committed to helping your patients achieve their PTH goals. Learn more about the Hectorol 1 mcg Promise.
For more information on the Hectorol Start Card, call Renassist℗ at 1-800-847-0069.
If you are a privately insured patient residing in Massachusetts, you are not eligible to use the Hectorol Start Card.
* Prescriptions for 0.5 mcg, 1 mcg, 2.5 mcg are covered with the Start Card.
† Maximum benefit of the Hectorol Start Card is $200 per refill.
hec_p_safety_info
Important Information About Hectorol®
Hectorol is indicated for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 Chronic Kidney Disease (capsules) and in patients with Chronic Kidney Disease on dialysis (capsules and injection). Important Treatment Considerations
- Hectorol is contraindicated in patients with a tendency towards hypercalcemia or current evidence of vitamin D toxicity.
- Overdosage of any form of vitamin D is dangerous.
- Acute hypercalcemia may exacerbate tendencies for cardiac arrhythmias and seizures and may potentiate the action of digitalis drugs.
- Chronic hypercalcemia can lead to generalized vascular and soft tissue calcification.
- Pharmacologic doses of vitamin D and its derivatives should be withheld during Hectorol treatment to avoid possible additive effects and hypercalcemia.
- Magnesium-containing antacids and Hectorol should not be administered concomitantly.
- Adverse effects of Hectorol treatment are: hypercalcemia, hyperphosphatemia, hypercalciuria, and oversuppression of iPTH.
- Adverse events reported by ≥ 5% of the Hectorol-treated predialysis patients included: infection, chest pain, constipation, dyspepsia, anemia, dehydration, depression, hypertonia, insomnia, paresthesia, increased cough, dyspnea, and rhinitis.
- Adverse events reported by ≥ 5% of the Hectorol-treated dialysis patients included: headache, malaise, bradycardia, nausea/vomiting, edema, dizziness, dyspnea, and pruritus.
- See
Hectorol Capsules Full Prescribing Information or Hectorol Injection Full Prescribing Information or call Genzyme Medical Information at 1-800-847-0069.
|
|
 |
|
|
|
| Contact |
Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142
T: 800 847 0069
F: 617 252 7600
Email Us
|
 |
|
|
|
|
